RYOIX vs. FBTAX
Compare and contrast key facts about Rydex Biotechnology Fund (RYOIX) and Fidelity Advisor Biotechnology Fund Class A (FBTAX).
RYOIX is managed by Rydex Funds. It was launched on Mar 31, 1998. FBTAX is managed by Fidelity. It was launched on Dec 27, 2000.
Performance
RYOIX vs. FBTAX - Performance Comparison
Loading graphics...
RYOIX vs. FBTAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RYOIX Rydex Biotechnology Fund | 2.04% | 30.62% | -0.95% | 6.06% | -13.04% | 2.05% | 21.94% | 30.69% | -8.94% | 29.68% |
FBTAX Fidelity Advisor Biotechnology Fund Class A | 2.24% | 39.54% | 5.37% | 10.70% | -7.95% | -3.10% | 32.17% | 25.74% | -3.86% | 25.80% |
Returns By Period
In the year-to-date period, RYOIX achieves a 2.04% return, which is significantly lower than FBTAX's 2.24% return. Over the past 10 years, RYOIX has underperformed FBTAX with an annualized return of 9.00%, while FBTAX has yielded a comparatively higher 11.86% annualized return.
RYOIX
- 1D
- 5.02%
- 1M
- -1.74%
- YTD
- 2.04%
- 6M
- 14.85%
- 1Y
- 38.77%
- 3Y*
- 12.70%
- 5Y*
- 4.57%
- 10Y*
- 9.00%
FBTAX
- 1D
- 5.08%
- 1M
- -0.75%
- YTD
- 2.24%
- 6M
- 15.54%
- 1Y
- 55.40%
- 3Y*
- 20.44%
- 5Y*
- 8.92%
- 10Y*
- 11.86%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
RYOIX vs. FBTAX - Expense Ratio Comparison
RYOIX has a 1.36% expense ratio, which is higher than FBTAX's 1.00% expense ratio.
Return for Risk
RYOIX vs. FBTAX — Risk / Return Rank
RYOIX
FBTAX
RYOIX vs. FBTAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rydex Biotechnology Fund (RYOIX) and Fidelity Advisor Biotechnology Fund Class A (FBTAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RYOIX | FBTAX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.51 | 1.94 | -0.42 |
Sortino ratioReturn per unit of downside risk | 2.12 | 2.53 | -0.41 |
Omega ratioGain probability vs. loss probability | 1.27 | 1.33 | -0.06 |
Calmar ratioReturn relative to maximum drawdown | 2.55 | 3.16 | -0.60 |
Martin ratioReturn relative to average drawdown | 10.27 | 12.63 | -2.35 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| RYOIX | FBTAX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.51 | 1.94 | -0.42 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.22 | 0.38 | -0.17 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.39 | 0.48 | -0.10 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.36 | 0.31 | +0.05 |
Correlation
The correlation between RYOIX and FBTAX is 0.96, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
RYOIX vs. FBTAX - Dividend Comparison
RYOIX's dividend yield for the trailing twelve months is around 12.32%, more than FBTAX's 1.42% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RYOIX Rydex Biotechnology Fund | 12.32% | 12.57% | 14.61% | 0.00% | 1.29% | 19.39% | 7.28% | 8.58% | 14.11% | 5.38% | 0.00% | 1.45% |
FBTAX Fidelity Advisor Biotechnology Fund Class A | 1.42% | 1.45% | 6.00% | 1.15% | 0.00% | 20.12% | 8.37% | 6.77% | 2.50% | 0.00% | 0.00% | 5.36% |
Drawdowns
RYOIX vs. FBTAX - Drawdown Comparison
The maximum RYOIX drawdown since its inception was -74.43%, which is greater than FBTAX's maximum drawdown of -63.55%. Use the drawdown chart below to compare losses from any high point for RYOIX and FBTAX.
Loading graphics...
Drawdown Indicators
| RYOIX | FBTAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.43% | -63.55% | -10.88% |
Max Drawdown (1Y)Largest decline over 1 year | -12.10% | -13.60% | +1.50% |
Max Drawdown (5Y)Largest decline over 5 years | -33.66% | -36.51% | +2.85% |
Max Drawdown (10Y)Largest decline over 10 years | -33.66% | -38.82% | +5.16% |
Current DrawdownCurrent decline from peak | -2.87% | -2.54% | -0.33% |
Average DrawdownAverage peak-to-trough decline | -27.80% | -21.34% | -6.46% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.14% | 3.71% | -0.57% |
Volatility
RYOIX vs. FBTAX - Volatility Comparison
The current volatility for Rydex Biotechnology Fund (RYOIX) is 8.55%, while Fidelity Advisor Biotechnology Fund Class A (FBTAX) has a volatility of 9.36%. This indicates that RYOIX experiences smaller price fluctuations and is considered to be less risky than FBTAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| RYOIX | FBTAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.55% | 9.36% | -0.81% |
Volatility (6M)Calculated over the trailing 6-month period | 14.04% | 17.00% | -2.96% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.43% | 26.00% | -2.57% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.16% | 23.32% | -2.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.37% | 24.59% | -1.22% |